2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European…

By G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, M. Böhm, T. Christiaens, R. Cífková, G. Backer, A. Dominiczak and 79 more. European Heart Journal, 2013

2,440 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Economics and Econometrics

View Paper: https://www.semanticscholar.org/paper/a139b43045e2102a7a45c75c39cfced42ba4e83b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016, methodology): “pressure measurement should be considered and lifestyle modification encouraged.(166) After the initiation of VEGF inhibitors, early detection and”
Endothelial Dysfunction and Hypertension. (2016, background): “Despite the difficulty of distinguishing the possible direct effects of antihypertensive drugs on endothelial function from indirect protection secondary to the decreased blood pressure, the effects of various antihypertensive drugs on endothelial dysfunction have been tested (Mancia et al. 2013).”
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016, background): “When white-coat hypertension is suspected, ambulatory blood pressure measurement should be considered and lifestyle modification encouraged.(166) After the initiation of VEGF inhibitors, early detection and reactive management of blood pressure elevations are necessary”
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management (2011, methodology): “Emerging evidence on the prognostic value of heart rate have led to the advice in the current hypertension guidelines to measure heart rate in clinical practice [36] and to use it for cardiovascular risk stratification and as therapeutic target in high-risk patients [25,36].”
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. (2014, methodology): “grade 1 hypertension is a class IIa recommendation in new European guidelines.(41) Most recent US guidelines have adopted”
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. (2015, methodology): “Current status in clinical practice guidelines: TheESH/ESCguidelines for themanagementof hypertension state that ABI should be considered for detecting PAD in hypertensives (class IIa/B recommendation) [23]; the same holds true in the ESC guidelines for CV disease prevention in individuals at interm”
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? (2018, background): “The validation of NAFLD as an independent risk factor would have direct relevance for primary preventive strategies against CVD. NAFLD increases risk of CVD An initial description of a significant association between NAFLD and the risk of incident CVD was published in the early 2000s.”
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “Treatment according to current guidelines is recommended in patients with known hypertension.(489)”